147 related articles for article (PubMed ID: 1824824)
1. Protein kinase C activity and multidrug resistance in MOLT-3 human lymphoblastic leukemia cells resistant to trimetrexate.
Schwartz GK; Arkin H; Holland JF; Ohnuma T
Cancer Res; 1991 Jan; 51(1):55-61. PubMed ID: 1824824
[TBL] [Abstract][Full Text] [Related]
2. Multidrug resistance in a human leukemic cell line selected for resistance to trimetrexate.
Arkin H; Ohnuma T; Kamen BA; Holland JF; Vallabhajosula S
Cancer Res; 1989 Dec; 49(23):6556-61. PubMed ID: 2573416
[TBL] [Abstract][Full Text] [Related]
3. N10-propargyl-5,8-dideazafolic acid (CB3717): inhibitory effects on human leukemia cell lines resistant to methotrexate or trimetrexate.
Takemura Y; Ohnuma T
Mt Sinai J Med; 1992 Oct; 59(5):419-24. PubMed ID: 1435841
[TBL] [Abstract][Full Text] [Related]
4. Functional role of phosphorylation of the multidrug transporter (P-glycoprotein) by protein kinase C in multidrug-resistant MCF-7 cells.
Aftab DT; Yang JM; Hait WN
Oncol Res; 1994; 6(2):59-70. PubMed ID: 7949466
[TBL] [Abstract][Full Text] [Related]
5. Role of protein kinase C in the modulation of multidrug resistance: expression of the atypical gamma isoform of protein kinase C does not confer increased resistance to doxorubicin.
Ahmad S; Trepel JB; Ohno S; Suzuki K; Tsuruo T; Glazer RI
Mol Pharmacol; 1992 Dec; 42(6):1004-9. PubMed ID: 1362242
[TBL] [Abstract][Full Text] [Related]
6. Elevated level of nuclear protein kinase C in multidrug-resistant MCF-7 human breast carcinoma cells.
Lee SA; Karaszkiewicz JW; Anderson WB
Cancer Res; 1992 Jul; 52(13):3750-9. PubMed ID: 1617646
[TBL] [Abstract][Full Text] [Related]
7. [Correlation of protein kinase C activity and its subcellular distrubution with multidrug resistance in KVB200 cells].
Sun AM; Yuan YW; Li CG; Chen J; Xiao MX; Zhao MF
Di Yi Jun Yi Da Xue Xue Bao; 2002 Feb; 22(2):121-3. PubMed ID: 12390803
[TBL] [Abstract][Full Text] [Related]
8. Protein kinase C in adriamycin action and resistance in mouse sarcoma 180 cells.
Posada J; Vichi P; Tritton TR
Cancer Res; 1989 Dec; 49(23):6634-9. PubMed ID: 2819714
[TBL] [Abstract][Full Text] [Related]
9. Involvement of the alpha isoenzyme of protein kinase C in the growth inhibition induced by phorbol esters in MH1C1 hepatoma cells.
Perletti GP; Smeraldi C; Porro D; Piccinini F
Biochem Biophys Res Commun; 1994 Dec; 205(3):1589-94. PubMed ID: 7811240
[TBL] [Abstract][Full Text] [Related]
10. Establishment of methotrexate-resistant human acute lymphoblastic leukemia cells in culture and effects of folate antagonists.
Ohnoshi T; Ohnuma T; Takahashi I; Scanlon K; Kamen BA; Holland JF
Cancer Res; 1982 May; 42(5):1655-60. PubMed ID: 6978176
[TBL] [Abstract][Full Text] [Related]
11. Patterns of cross-resistance to the antifolate drugs trimetrexate, metoprine, homofolate, and CB3717 in human lymphoma and osteosarcoma cells resistant to methotrexate.
Diddens H; Niethammer D; Jackson RC
Cancer Res; 1983 Nov; 43(11):5286-92. PubMed ID: 6225514
[TBL] [Abstract][Full Text] [Related]
12. Activation of the LRP (lung resistance-related protein) gene by short-term exposure of human leukemia cells to phorbol ester and cytarabine.
Komarov PG; Shtil AA; Holian O; Tee L; Buckingham L; Mechetner EB; Roninson IB; Coon JS
Oncol Res; 1998; 10(4):185-92. PubMed ID: 9778689
[TBL] [Abstract][Full Text] [Related]
13. Reduced daunomycin accumulation in drug-sensitive and multidrug-resistant human carcinoma KB cells following phorbol ester treatment: a potential role for protein kinase C in reducing drug influx.
Drew L; Groome N; Warr JR; Rumsby MG
Oncol Res; 1996; 8(6):249-57. PubMed ID: 8895200
[TBL] [Abstract][Full Text] [Related]
14. Effect of protein kinase C on multidrug resistance of multidrug-resistant colorectal cancer LoVo/Adr cells.
Ma Q; Zhang ZS; Zhang YL; Wang QY; Lai ZS
Di Yi Jun Yi Da Xue Xue Bao; 2002 Jul; 22(7):626-8. PubMed ID: 12376294
[TBL] [Abstract][Full Text] [Related]
15. In vitro model for intrinsic drug resistance: effects of protein kinase C activators on the chemosensitivity of cultured human colon cancer cells.
Dong ZY; Ward NE; Fan D; Gupta KP; O'Brian CA
Mol Pharmacol; 1991 Apr; 39(4):563-9. PubMed ID: 2017156
[TBL] [Abstract][Full Text] [Related]
16. Changes in protein kinase C subspecies protein expression and activity in a series of multidrug-resistant human KB carcinoma cell lines.
Drew L; Groome N; Hallam TJ; Warr JR; Rumsby MG
Oncol Res; 1994; 6(9):429-38. PubMed ID: 7703529
[TBL] [Abstract][Full Text] [Related]
17. Cellular and biochemical characterization of thioxanthenes for reversal of multidrug resistance in human and murine cell lines.
Ford JM; Bruggemann EP; Pastan I; Gottesman MM; Hait WN
Cancer Res; 1990 Mar; 50(6):1748-56. PubMed ID: 1968358
[TBL] [Abstract][Full Text] [Related]
18. Activation of MDR1 (P-glycoprotein) gene expression in human cells by protein kinase C agonists.
Chaudhary PM; Roninson IB
Oncol Res; 1992; 4(7):281-90. PubMed ID: 1360276
[TBL] [Abstract][Full Text] [Related]
19. Protein kinase inhibitor, staurosporine, induces a mature neuronal phenotype in SH-SY5Y human neuroblastoma cells through an alpha-, beta-, and zeta-protein kinase C-independent pathway.
Jalava A; Akerman K; Heikkilä J
J Cell Physiol; 1993 May; 155(2):301-12. PubMed ID: 8482723
[TBL] [Abstract][Full Text] [Related]
20. Decreased phorbol ester receptor and protein kinase C in P388 murine leukemic cells resistant to etoposide.
Ido M; Sato K; Sakurai M; Inagaki M; Saitoh M; Watanabe M; Hidaka H
Cancer Res; 1987 Jul; 47(13):3460-3. PubMed ID: 3581082
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
